These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 32393850)

  • 1. Correction: Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer.
    Gao M; Lin M; Moffitt RA; Salazar MA; Park J; Vacirca J; Huang C; Shroyer KR; Choi M; Georgakis GV; Sasson AR; Talamini MA; Kim J
    Br J Cancer; 2020 Aug; 123(3):495. PubMed ID: 32393850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Author Correction: Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells.
    Knox T; Sahakian E; Banik D; Hadley M; Palmer E; Noonepalle S; Kim J; Powers J; Gracia-Hernandez M; Oliveira V; Cheng F; Chen J; Barinka C; Pinilla-Ibarz J; Lee NH; Kozikowski A; Villagra A
    Sci Rep; 2019 Oct; 9(1):14824. PubMed ID: 31597938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: Molecular subtypes of oropharyngeal cancer show distinct immune microenvironment related with immune checkpoint blockade response.
    Kim MH; Kim JH; Lee JM; Choi JW; Jung D; Cho H; Kang H; Hong MH; Heo SJ; Kim SH; Choi EC; Kim DH; Park YM; Kim S; Yoon SO; Koh YW; Cho BC; Kim HR
    Br J Cancer; 2020 Sep; 123(6):1041. PubMed ID: 32572173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Publisher Correction: Antibody engineers seek optimal drug targeting TIGIT checkpoint.
    Dolgin E
    Nat Biotechnol; 2020 Nov; 38(11):1357. PubMed ID: 32999474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Author Correction: Hyperprogression under Immune Checkpoint Inhibitor: a potential role for germinal immunogenetics.
    Refae S; Gal J; Brest P; Giacchero D; Borchiellini D; Ebran N; Peyrade F; Guigay J; Milano G; Saada-Bouzid E
    Sci Rep; 2020 Jun; 10(1):9857. PubMed ID: 32528006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Author Correction: Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic Cancer.
    Zhu G; Foletti D; Liu X; Ding S; Melton Witt J; Hasa-Moreno A; Rickert M; Holz C; Aschenbrenner L; Yang AH; Kraynov E; Evering W; Obert L; Lee C; Sai T; Mistry T; Lindquist KC; Van Blarcom T; Strop P; Chaparro-Riggers J; Liu SH
    Sci Rep; 2019 Nov; 9(1):16735. PubMed ID: 31700121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: Macrophage-derived CCL5 facilitates immune escape of colorectal cancer cells via the p65/STAT3-CSN5-PD-L1 pathway.
    Liu C; Yao Z; Wang J; Zhang W; Yang Y; Zhang Y; Qu X; Zhu Y; Zou J; Peng S; Zhao Y; Zhao S; He B; Mi Q; Liu X; Zhang X; Du Q
    Cell Death Differ; 2020 Jul; 27(7):2293. PubMed ID: 32024980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Author Correction: High PD-L1 expression is associated with therapeutic response to pembrolizumab in patients with advanced biliary tract cancer.
    Ahn S; Lee JC; Shin DW; Kim J; Hwang JH
    Sci Rep; 2020 Dec; 10(1):21552. PubMed ID: 33273671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: Desperately seeking…Models to find the right partner and the best use for checkpoint inhibitors.
    Bertolini F
    Br J Cancer; 2019 Oct; 121(9):808. PubMed ID: 31551582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Author Correction: Real-world evidence and clinical observations of the treatment of advanced non-small cell lung cancer with PD-1/PD-L1 inhibitors.
    Song P; Zhang J; Shang C; Zhang L
    Sci Rep; 2020 Jan; 10(1):1525. PubMed ID: 31988322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Author Correction: Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance.
    Zhang J; Bu X; Wang H; Zhu Y; Geng Y; Nihira NT; Tan Y; Ci Y; Wu F; Dai X; Guo J; Huang YH; Fan C; Ren S; Sun Y; Freeman GJ; Sicinski P; Wei W
    Nature; 2019 Jul; 571(7766):E10. PubMed ID: 31270456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: Global analysis of human glycosyltransferases reveals novel targets for pancreatic cancer pathogenesis.
    Gupta R; Leon F; Thompson CM; Nimmakayala R; Karmakar S; Nallasamy P; Chugh S; Prajapati DR; Rachagani S; Kumar S; Ponnusamy MP
    Br J Cancer; 2020 May; 122(11):1726. PubMed ID: 32286491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver.
    Gray MJ; Dallas NA; Van Buren G; Xia L; Yang AD; Somcio RJ; Gaur P; Mangala LS; Vivas-Mejia PE; Fan F; Sanguino AM; Gallick GE; Lopez-Berestein G; Sood AK; Ellis LM
    Oncogene; 2020 Jun; 39(23):4619. PubMed ID: 32366906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer.
    Michaelis KA; Norgard MA; Zhu X; Levasseur PR; Sivagnanam S; Liudahl SM; Burfeind KG; Olson B; Pelz KR; Ramos DMA; Maurer HC; Olive KP; Coussens LM; Morgan TK; Marks DL
    Nat Commun; 2019 Nov; 10(1):5257. PubMed ID: 31729370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Author Correction: Drug-induced PD-L1 expression and cell stress response in breast cancer cells can be balanced by drug combination.
    Gilad Y; Eliaz Y; Yu Y; Han SJ; O'Malley BW; Lonard DM
    Sci Rep; 2020 Mar; 10(1):4463. PubMed ID: 32132607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Publisher Correction: Profiling the susceptibility of Pseudomonas aeruginosa strains from acute and chronic infections to cell-wall-targeting immune proteins.
    Torrens G; Barceló IM; Pérez-Gallego M; Escobar-Salom M; Tur-Gracia S; Munar-Bestard M; González-Nicolau MDM; Cabrera-Venegas YJ; Rigo-Rumbos EN; Cabot G; López-Causapé C; Rojo-Molinero E; Oliver A; Juan C
    Sci Rep; 2020 Mar; 10(1):4356. PubMed ID: 32132557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Author Correction: Improved ethanol electrooxidation performance by shortening Pd-Ni active site distance in Pd-Ni-P nanocatalysts.
    Chen L; Lu L; Zhu H; Chen Y; Huang Y; Li Y; Wang L
    Nat Commun; 2020 Mar; 11(1):1333. PubMed ID: 32152306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: Desperately seeking…Models to find the right partner and the best use for checkpoint inhibitors.
    Bertolini F
    Br J Cancer; 2019 Oct; 121(7):627. PubMed ID: 31427683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction: Role of integrin-linked kinase in regulating the protein stability of the MUC1-C oncoprotein in pancreatic cancer cells.
    Huang HL; Wu HY; Chu PC; Lai IL; Huang PH; Kulp SK; Pan SL; Teng CM; Chen CS
    Oncogenesis; 2020 Feb; 9(2):27. PubMed ID: 32102990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Author Correction: 3D-printed vascular networks direct therapeutic angiogenesis in ischaemia.
    Mirabella T; MacArthur JW; Cheng D; Ozaki CK; Woo YJ; Yang M; Chen CS
    Nat Biomed Eng; 2020 May; 4(5):572. PubMed ID: 32251393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.